OTC cough/cold dosing proposal on FDA agenda
This article was originally published in The Tan Sheet
FDA plans to publish a proposed rulemaking regarding pediatric dosing of OTC cough/cold products in June 2010, according to the Department of Health and Human Services' semi-annual regulatory 1agenda published Dec. 7. The agency intends to publish in May a final rule on the OTC sunscreen monograph and a final rule for OTC weight-control products containing benzocaine, and in September a proposed rule regarding OTC antihistamine labeling claims for the common cold. Other longer-term actions with undetermined completion dates include a proposed rule on oral care products to reduce or prevent plaque and gingivitis, and a final action on OTC drugs containing bismuth subsalicylate for relieving upset stomach caused by overeating. The HHS agenda released in May targeted September for the pediatric cough/cold and sunscreen actions (2"The Tan Sheet" May 25, 2009). Regulatory agendas are not binding on agencies and often list repeatedly delayed rulemakings
You may also be interested in...
Concern about the safety of triclosan has Rep. Ed Markey pressuring FDA to finalize the OTC Topical Antimicrobial Drug monograph, first proposed in 1972
Concern about the safety of triclosan prompts a lawmaker to pressure FDA to finalize the OTC Topical Antimicrobial Drug monograph, first proposed in 1972
Meeting deadlines on regulatory agenda actions, such as finalizing OTC monographs, could be a higher priority for FDA under its new management